H. Mitani

发表

Inhibitory effects of fluvastatin, a new HMG‐CoA reductase inhibitor, on the increase in vascular ACE activity in cholesterol‐fed rabbits

H. Mitani, T. Bandoh, Junji Ishikawa, 1996, British journal of pharmacology.

Hypoglycemic and hypotensive effects of 6-cyclohexyl-2'-O-methyl-adenosine, an adenosine A1 receptor agonist, in spontaneously hypertensive rat complicated with hyperglycemia.

T. Totsuka, M. Kimura, J. Ishikawa, 1998, Diabetes research and clinical practice.

Preservation of Endothelium‐Dependent and Nω‐Nitro‐L‐Arginine Methyl Ester‐ and Indomethacin‐Resistant Arterial Relaxation in High‐Cholesterol‐Diet Fed Rabbits by Treatment with Fluvastatin, an HMG‐CoA Reductase Inhibitor

H. Mitani, M. Kimura, 2003, Journal of cardiovascular pharmacology.

Dipeptidyl peptidase IV inhibition improves impaired glucose tolerance in high-fat diet-fed rats: study using a Fischer 344 rat substrain deficient in its enzyme activity.

T. Hughes, H. Mitani, M. Kimura, 2002, Japanese journal of pharmacology.

Dipeptidyl peptidase IV inhibitor NVP-DPP728 ameliorates early insulin response and glucose tolerance in aged rats but not in aged Fischer 344 rats lacking its enzyme activity.

H. Mitani, M. Kimura, M. Takimoto, 2002, Japanese journal of pharmacology.

Insulin down-regulates specific activity of ATP-binding cassette transporter A1 for high density lipoprotein biogenesis through its specific phosphorylation.

S. Yokoyama, S. Abe-Dohmae, H. Mitani, 2011, Atherosclerosis.

Inhibitory effect of fluvastatin at doses insufficient to lower serum lipids on the catheter-induced thickening of intima in rabbit femoral artery.

Y. Kusumi, J. Ishikawa, H. Mitani, 1996, European journal of pharmacology.

Expression, secretion, and inhibition of angiotensin-converting enzyme in cultured human bronchial epithelial cells.

S. Hori, H. Mitani, T. Bandoh, 1999, European journal of pharmacology.

Increased activity of vascular ACE related to atherosclerotic lesions in hyperlipidemic rabbits.

T. Totsuka, H. Mitani, T. Bandoh, 1996, The American journal of physiology.

Synthesis and structure-activity relationship of RXR antagonists based on the diazepinylbenzoic acid structure.

T. Kanazawa, Hidefumi Uchiyama, H. Mitani, 2007, Bioorganic & medicinal chemistry letters.

Fluvastatin suppresses atherosclerotic progression, mediated through its inhibitory effect on endothelial dysfunction, lipid peroxidation, and macrophage deposition.

Y. Kusumi, J. Ishikawa, H. Mitani, 2000, Journal of cardiovascular pharmacology.

HMG-CoA reductase inhibitor, fluvastatin, has cholesterol-lowering independent "direct" effects on atherosclerotic vessels in high cholesterol diet-fed rabbits.

K. Egashira, H. Mitani, M. Kimura, 2003, Pharmacological research.

Discovery of a Novel Piperidine-Based Inhibitor of Cholesteryl Ester Transfer Protein (CETP) That Retains Activity in Hypertriglyceridemic Plasma.

O. Ohmori, Kayo Yasoshima, Ken Yamada, 2017, Journal of medicinal chemistry.

Preservation of Endothelial Function by the HMG-CoA Reductase Inhibitor Fluvastatin through Its Lipid-Lowering Independent Antioxidant Properties in Atherosclerotic Rabbits

K. Egashira, N. Ohashi, M. Yoshikawa, 2003, Pharmacology.

Antioxidative potential of fluvastatin via the inhibition of nicotinamide adenine dinucleotide phosphate (NADPH) oxidase activity.

E. Sato, M. Inoue, K. Hoshi, 2003, Biological & pharmaceutical bulletin.

Fluvastatin, HMG‐CoA Reductase Inhibitor: Antiatherogenic Profiles Through Its Lipid‐Lowering–Dependent and ‐Independent Actions

H. Mitani, M. Kimura, 2006 .

Increases of vascular endothelin-converting enzyme activity and endothelin-1 level on atherosclerotic lesions in hyperlipidemic rabbits.

H. Mitani, T. Bandoh, M. Kimura, 2000, European journal of pharmacology.

Synthesis and structure-activity relationship of novel RXR antagonists: orally active anti-diabetic and anti-obesity agents.

T. Kanazawa, Y. Matsumoto, Hidefumi Uchiyama, 2007, Bioorganic & medicinal chemistry letters.

Mast cell degranulation in rat mesenteric venule: effects of L-NAME, methylene blue and ketotifen.

T. Totsuka, H. Mitani, T. Bandoh, 1999, Pharmacological research.